For those with $200 to spare that isn't being saved for emergencies, let's consider two healthcare stocks within that budget that are worth holding onto forever: Bristol Myers Squibb (NYSE: BMY) and ...

GSK has fired a shot across the bows of Gilead Sciences' HIV juggernaut Biktarvy, with new data showing its rival therapy Dovato is as effective but causes less weight gain. The results of the ...

If you’re shopping on a budget, the best vacuums under $200 will be a bit easier on your wallet, and they deliver just as much dirt-busting power as more expensive alternatives. Over the past ...

You’ve reached your account maximum for followed topics. When it comes to high-performance cars, reaching the elusive 200 mph mark is often seen as a feat only reserved for half-a-million-dollar ...

billboard global 200 the week's most popular songs based on streaming and sales activity from over 200 territories around the world — including the united states — as tracked by luminate. the ...

Desiree DeNunzio is the gift guide editor for CNET's Commerce team. When she's not writing and editing, she's either hiking through the redwoods or curled up with a good book and a lazy dog ...

Model year 2015 brought another redesign. While it represents a vast improvement over the 2011 model, the 200 continues to trail the field by a considerable margin. This is largely owing to klutzy ...

Biktarvy's revenue came in at $3.2 billion ... That's yet another reason to hold this stock for good -- at a price of $79 per share, $200 gets you two of them. Prosper Junior Bakiny has no ...

For those with $200 to spare that isn't being saved for ... The biotech currently boasts the top prescribed HIV regimen in the U.S.: Biktarvy. This medicine's revenue and market share have ...